Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 13/20 | 0.76 |
| ▸ | PLG | P00747 | 7/20 | 0.62 |
| ▸ | PRSS1 | P07477 | 7/20 | 0.62 |
| ▸ | PRSS2 | P07478 | 7/20 | 0.62 |
| ▸ | PRSS3 | P35030 | 7/20 | 0.62 |
| ▸ | PLAU | P00749 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23553003 | 1.00 | FOLH1 (0.76) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL29679477 | 1.00 | FOLH1 (0.76) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL26090338 | 1.00 | FOLH1 (0.76) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL28659047 | 1.00 | FOLH1 (0.76) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL22883093 | 0.93 | FOLH1 (0.75) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL19296397 | 0.92 | FOLH1 (0.76) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL27303660 | 0.92 | FOLH1 (0.73) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL26178698 | 0.92 | FOLH1 (0.78) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL26001462 | 0.92 | FOLH1 (0.78) | FOLH1PLGPRSS1PRSS2PRSS3 | |
| SCHEMBL22883091 | 0.91 | FOLH1 (0.72) | FOLH1PLGPRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332296-A1 | ZWITTERIONIC METAL CHELATORS | CURADEL SURGICAL INNOVATIONS, INC. (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250332295-A1 | ZWITTERIONIC METAL CHELATORS | CURADEL SURGICAL INNOVATIONS, INC. (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250325713-A1 | DISEASE-TARGETED IMAGING AGENTS | CURADEL SURGICAL INNOVATIONS INC (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250325712-A1 | TARGETING LIGANDS FOR DISEASE-TARGETED IMAGING AGENTS AND METHODS OF USE THEREFOR | CURADEL SURGICAL INNOVATIONS INC (US) | 2025-10-23 | — | — | US | disclosed |
| US-12440585-B2 | Zwitterionic metal chelators | CURADEL SURGICAL INNOVATIONS, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| WO-2025059116-A1 | COMBINATIONS OF IMAGING AGENT CONJUGATES AND APPLICATION THEREOF | CURADEL SURGICAL INNOVATIONS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025059124-A1 | N-OXIDE BASED ZWITTERIONIC NEAR INFRARED FLUOROPHORE IMAGING AGENTS AND METHODS OF USE THEREFOR | CURADEL SURGICAL INNOVATIONS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| US-20250090697-A1 | ZWITTERIONIC METAL CHELATORS | CURADEL SURGICAL INNOVATIONS, INC. | 2025-03-20 | — | — | US | disclosed |
| WO-2025059097-A1 | DISEASE-TARGETED IMAGING AGENTS | CURADEL SURGICAL INNOVATIONS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025059044-A1 | TARGETING LIGANDS FOR DISEASE-TARGETED IMAGING AGENTS AND METHODS OF USE THEREFOR | CURADEL SURGICAL INNOVATIONS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| US-20250082795-A1 | COMBINATIONS OF IMAGING AGENT CONJUGATES AND APPLICATION THEREOF | CURADEL SURGICAL INNOVATIONS, INC. | 2025-03-13 | — | — | US | disclosed |
| US-20250082792-A1 | ZWITTERIONIC METAL CHELATORS | CURADEL SURGICAL INNOVATIONS, INC. | 2025-03-13 | — | — | US | disclosed |
| WO-2024222575-A1 | MACROCYCLIC CHELATING AGENT CAPABLE OF SITE-SPECIFIC MODIFICATION, RADIONUCLIDE PROBE, AND USE THEREOF | 中国科学院上海药物研究所 | 2024-10-31 | — | — | WO | disclosed |
| EP-4003959-A1 | TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | Bayer AS (NO) | 2022-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12440585-B2 | Zwitterionic metal chelators | SLC39A14, SLC7A1, SLC39A11 | FOLH1 66/4885PLG 1194/4885PRSS1 2771/4885 |
| US-20250332295-A1 | ZWITTERIONIC METAL CHELATORS | SLC39A14, SLC7A1, SLC39A11 | FOLH1 66/4885PLG 1194/4885PRSS1 2771/4885 |
| US-20250325712-A1 | TARGETING LIGANDS FOR DISEASE-TARGETED IMAGING AGENTS AND METHODS OF USE THEREFOR | LGALS1, LGALS8, CD74 | FOLH1 20/4885PLG 514/4885PRSS1 1685/4885 |
| US-20250325713-A1 | DISEASE-TARGETED IMAGING AGENTS | FAP, PROKR1, GRPR | FOLH1 52/4885PLG 1335/4885PRSS1 271/4885 |
| US-20250082795-A1 | COMBINATIONS OF IMAGING AGENT CONJUGATES AND APPLICATION THEREOF | FAM83E, FAM83A, BMPR1A | FOLH1 293/4885PLG 439/4885PRSS1 907/4885 |
| US-20250082792-A1 | ZWITTERIONIC METAL CHELATORS | SLC39A14, SLC7A1, SLC39A11 | FOLH1 66/4885PLG 1194/4885PRSS1 2771/4885 |
| US-20250090697-A1 | ZWITTERIONIC METAL CHELATORS | SLC39A14, SLC7A1, SLC39A11 | FOLH1 66/4885PLG 1194/4885PRSS1 2771/4885 |
| US-20250332296-A1 | ZWITTERIONIC METAL CHELATORS | SLC39A14, SLC7A1, SLC39A11 | FOLH1 66/4885PLG 1194/4885PRSS1 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.